用于功能性食品包装的残留物的价值化
Gréta Törős1,2, Hassan El-Ramady3, Neama Abdalla4
1Institute of Animal Science, Biotechnology and Nature Conservation, Faculty of Agricultural and Food Sciences and Environmental Management, University of Debrecen, Böszörményi Street 138, 4032 Debrecen, Hungary.
International journal of molecular sciences
|November 27, 2025
概括
富含生物活性化合物的残留物可以转化为可持续的食品包装. 这种循环经济方法提高了包装的性能,减少了浪费.
科学领域:
- 生物材料科学 生物材料科学
- 可持续化学 可持续化学
- 食品科学 食品科学 食品科学
背景情况:
- 产业每年产生大量的残留物,通常被丢弃.
- 这些残留物含有宝贵的生物活性化合物,如β-glucans和具有抗氧化和抗微生物特性的化合物.
- 残留物是开发可持续材料的未充分利用的资源,与广泛研究的水果和蔬菜废物不同.
研究的目的:
- 探索残留物作为可持续食品包装中功能成分的可再生来源的潜力.
- 研究绿色提取技术的应用,以从废物中回收生物活性化合物.
- 为了评估含有残留提取物的可生物降解包装薄膜的性能.
主要方法:
- 使用绿色提取技术,特别是超声波和微波辅助方法,从残留物中回收生物活性化合物.
- 将这些回收的生物活性化合物纳入可生物降解的聚合物矩阵,以创建功能性包装膜.
- 评估开发的包装膜的机械强度,屏障性能和生物活性.
主要成果:
- 用残留提取物丰富的包装膜表现出更好的机械强度和增强的屏障性能.
- 添加提取物增加了包装材料的生物活性.
- 该研究表明,将废弃物转化为高价值包装解决方案的可行性.
结论:
- 残留物的价值化为开发下一代可持续和环保食品包装提供了一个有希望的途径.
- 这种方法与循环经济原则保持一致,通过减少废物和增加废弃生物质的价值.
- 建议进行进一步的研究,以优化提取效率,确保化合物稳定性,并解决工业应用的可扩展性.
相关概念视频
Fungal Group Zygomycota
961
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
961
Overview of Fungi
1.5K
Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
1.5K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
185
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
185


